ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1455

Mitochondrial Dysfunction in the Liver of Lupus-Prone MRL/Lpr Mice Prior to Disease Onset

Zachary A. Oaks1, Tiffany Telarico2 and Andras Perl3, 1SUNY, Syracuse, NY, 2Medicine, SUNY Upstate Medical University, Syracuse, NY, 3Dept of Medicine, SUNY Upstate Medical University, Syracuse, NY

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: mitochondria and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Liver dysfunction, characterized by serum elevation of liver enzymes, is detectable in 20% of patients with systemic lupus erythematosus (SLE.)  Males had a higher prevalence of liver dysfunction (12/33: 36%) than females (65/387; 18%; p=0.014; Yu and Perl submitted). Patients with SLE have mitochondrial dysfunction with increased mitochondrial mass and transmembrane potential, yet the biochemical consequences of mitochondrial accumulation in SLE have yet to be determined.  ATP generation is reduced in SLE, a process which is regulated by O2 consumption through the electron transport chain (ETC) of mitochondria.  Here, we characterize utilization of O2through the ETC and the generation of oxidative stress in pre-disease lupus-prone MRL/lpr mice to determine whether mitochondrial dysfunction precedes onset of SLE.

Methods: Mitochondrial ETC activity of isolated liver mitochondria was assessed in 4-week-old MRL/lpr lupus-prone mice as well as C57BL/6, MRL/MpJ, and Black 6/lpr age and gender-matched controls mice.  ETC was measured O2 with a Clark electrode.  State IV respiration, a measurement of O2 consumption through complex II, was measured by addition of succinate, ADP, and inorganic phosphate to isolated mitochondria.  Hydrogen peroxide (DCF-DA), superoxide (HE), peroxynitrite (DAR-4M), nitric oxide (DAF-FM),  mitochondrial potential (JC-1, TMRM), and mitochondrial mass (NAO) were measured by flow cytometry of isolated liver mitochondria.  Statistical analysis of data was done by paired t-tests and Pearson’s correlation analysis using GraphPad 5.0 software, with a cutoff of p<0.05 considered significant. 

Results: 4 week old male MRL/lpr mice exhibited increased mitochondrial respiratory capacity, measured by complex II respiration, in comparison to C57BL/6 (25.8%, p=.03) and Black 6/lpr (11.4%, p=.004) control strains.  Mitochondrial mass was increased in male MRL/lpr mice in comparison to C57BL/6 (+26.5%, p=.04) and Black 6/lpr (+55.5%, p=.001).  Male MRL/lpr mitochondria also had increased mitochondrial potential (+64.2%, p=.006), production of hydrogen peroxide (+60.0%, p=.02), superoxide (+72.4%, p=.03), nitric oxide (56.1%, p=.0004), and peroxynitrite (107.9%, p=.0005) relative to Black 6/lpr controls.  Mitochondrial potential positively correlated with production of hydrogen peroxide (r= 0.883, p=0.047), superoxide (r= 0.881, p=0.049), and peroxynitrite (r= 0.912, p=0.031).  MRL/lpr females had increased complex II state 4 respiration (+51.2%, p=0.02) relative to Black 6 controls.

Conclusion: Mitochondrial dysfunction, characterized by increased respiratory capacity and increased mitochondrial mass, precedes disease onset in lupus-prone MRL/lpr mice.   We show these changes correlate with increased production of reactive oxygen and nitrogen intermediates, which cause oxidative stress in SLE. Mitochondrial dysfunction in MRL/lpr was more robust in males than females that may account for a higher prevalence of liver disease in men than women with SLE.


Disclosure:

Z. A. Oaks,
None;

T. Telarico,
None;

A. Perl,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mitochondrial-dysfunction-in-the-liver-of-lupus-prone-mrllpr-mice-prior-to-disease-onset/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology